United Medical Systems

UMS provides three main shared mobile service programs for urology: Extracorporeal Shock Wave Lithotripsy (ESWL), MR Fusion targeted biopsy, and Laser Lithotripsy (URS). These are delivered using mobile equipment that UMS brings to healthcare provider facilities. The company supplies both the technology and the clinical staff needed for treatments. This model allows hospitals and clinics to offer these procedures without large capital outlays (per firm website).

UMS charges healthcare providers on a per-procedure or shared-service basis rather than selling or leasing equipment. The provider does not need to purchase the lithotripter or MRI fusion system upfront. UMS handles equipment maintenance, staffing, and logistics. This transaction-based model is distinct from an asset manager or investment firm (per firm website).

Yes. UMS has a Canadian subsidiary called United Medical Systems Canada, Inc., based in Port Colborne, Ontario. The firm's website lists both a US headquarters in Westborough, Massachusetts and this Canadian office. It is not known whether the firm operates in other countries beyond the US and Canada (per firm website).

No. UMS describes itself as a provider of shared healthcare services, specifically for urology procedures such as lithotripsy and MR fusion biopsy. Its business model is operational and service-oriented, not investment-based. No public information indicates it manages capital for an individual or family. The firm does not disclose AUM or any investment strategy (per firm website).

This information is not publicly disclosed. The firm's website does not list founders, executives, or board members. No known press or regulatory filings name the company's owners or management team. Therefore, the principals of the firm remain unknown (Altss research).